Search

Home > GRACEcast Lung Cancer Video > Dr. Geoffrey Oxnard on Managing Acquired Resistance to EGFR Inhibitor Therapy (and Probably Crizotinib, Too)
Podcast: GRACEcast Lung Cancer Video
Episode:

Dr. Geoffrey Oxnard on Managing Acquired Resistance to EGFR Inhibitor Therapy (and Probably Crizotinib, Too)
Category: Science & Medicine
Duration: 00:05:34
Publish Date: 2013-03-04 02:12:52
Description:

Dr. Geoffrey Oxnard, Dana Farber Cancer Institute, describes a wide range of options for best managing patients with advanced NSCLC who experience acquired resistance, the progression of cancer after a good initial response to a targeted therapy.
Total Play: 0